Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 3
2015 2
2017 2
2018 1
2019 3
2020 3
2021 4
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Effective reflection through near-peer education.
Yokoh H, Ito S. Yokoh H, et al. Clin Teach. 2020 Feb;17(1):113-114. doi: 10.1111/tct.13120. Epub 2019 Dec 9. Clin Teach. 2020. PMID: 31815363 No abstract available.
Correction of Hypercortisolemia with an Improved Cognitive Function and Muscle Mass after Transsphenoidal Surgery in an Older Patient with Cushing's Disease.
Terayama R, Ishikawa T, Ishiwata K, Sato A, Minamizuka T, Ohno T, Kono S, Yamamoto M, Yokoh H, Nagano H, Koshizaka M, Suzuki S, Koide H, Maezawa Y, Yokote K. Terayama R, et al. Among authors: yokoh h. Intern Med. 2022 Nov 15;61(22):3391-3399. doi: 10.2169/internalmedicine.8326-21. Epub 2022 Apr 30. Intern Med. 2022. PMID: 35491128 Free PMC article.
Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats.
Takeda K, Ono H, Ishikawa K, Ohno T, Kumagai J, Ochiai H, Matumoto A, Yokoh H, Maezawa Y, Yokote K. Takeda K, et al. Among authors: yokoh h. BMJ Open Diabetes Res Care. 2021 Apr;9(1):e002104. doi: 10.1136/bmjdrc-2020-002104. BMJ Open Diabetes Res Care. 2021. PMID: 33879516 Free PMC article.
Alternative approaches for clinical clerkship during the COVID-19 pandemic: online simulated clinical practice for inpatients and outpatients-A mixed method.
Kasai H, Shikino K, Saito G, Tsukamoto T, Takahashi Y, Kuriyama A, Tanaka K, Onodera M, Yokoh H, Tatusmi K, Yoshino I, Ikusaka M, Sakao S, Ito S. Kasai H, et al. Among authors: yokoh h. BMC Med Educ. 2021 Mar 8;21(1):149. doi: 10.1186/s12909-021-02586-y. BMC Med Educ. 2021. PMID: 33685442 Free PMC article.
Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME-V study).
Koshizaka M, Ishikawa K, Ishibashi R, Maezawa Y, Sakamoto K, Uchida D, Nakamura S, Yamaga M, Yokoh H, Kobayashi A, Onishi S, Kobayashi K, Ogino J, Hashimoto N, Tokuyama H, Shimada F, Ohara E, Ishikawa T, Shoji M, Ide S, Ide K, Baba Y, Hattori A, Kitamoto T, Horikoshi T, Shimofusa R, Takahashi S, Nagashima K, Sato Y, Takemoto M, Newby LK, Yokote K; PRIME-V study group. Koshizaka M, et al. Among authors: yokoh h. J Diabetes Investig. 2021 Feb;12(2):200-206. doi: 10.1111/jdi.13340. Epub 2020 Aug 20. J Diabetes Investig. 2021. PMID: 32623839 Free PMC article. Clinical Trial.
Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study.
Koshizaka M, Ishikawa K, Ishibashi R, Takahashi S, Sakamoto K, Yokoh H, Baba Y, Ide S, Ide K, Ishikawa T, Onishi S, Kobayashi K, Takemoto M, Horikoshi T, Shimofusa R, Maezawa Y, Yokote K. Koshizaka M, et al. Among authors: yokoh h. Diabetes Ther. 2021 Jan;12(1):183-196. doi: 10.1007/s13300-020-00949-0. Epub 2020 Oct 24. Diabetes Ther. 2021. PMID: 33098565 Free PMC article.
Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study).
Koshizaka M, Ishikawa K, Ishibashi R, Maezawa Y, Sakamoto K, Uchida D, Nakamura S, Yamaga M, Yokoh H, Kobayashi A, Onishi S, Kobayashi K, Ogino J, Hashimoto N, Tokuyama H, Shimada F, Ohara E, Ishikawa T, Shoji M, Ide S, Ide K, Baba Y, Hattori A, Kitamoto T, Horikoshi T, Shimofusa R, Takahashi S, Nagashima K, Sato Y, Takemoto M, Newby LK, Yokote K; PRIME-V Study Group. Koshizaka M, et al. Among authors: yokoh h. Diabetes Obes Metab. 2019 Aug;21(8):1990-1995. doi: 10.1111/dom.13750. Epub 2019 May 8. Diabetes Obes Metab. 2019. PMID: 30993861 Free PMC article. Clinical Trial.
17 results